APP and Alzheimer disease: Familial early-onset Alzheimer’s disease (FEOAD) or early-onset AD (EOAD) associated with dominant mutations in APP, PSEN1 and PSEN2 have a high penetrance for displaying many of the clinical symptoms associated with AD.